{"id":"NCT00014222","sponsor":"NCIC Clinical Trials Group","briefTitle":"Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer","officialTitle":"A Phase III Adjuvant Trial Of Sequenced EC + Filgrastim + Epoetin Alfa Followed By Paclitaxel Versus Sequenced AC Followed By Paclitaxel Versus CEF As Therapy For Premenopausal Women And Early Postmenopausal Women Who Have Had Potentially Curative Surgery For Node Positive Or High Risk Node Negative Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-12-04","primaryCompletion":"2014-02-10","completion":"2014-03-17","firstPosted":"2003-01-27","resultsPosted":"2020-03-10","lastUpdate":"2020-10-05"},"enrollment":2104,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"BIOLOGICAL","name":"epoetin alfa","otherNames":[]},{"type":"BIOLOGICAL","name":"filgrastim","otherNames":[]},{"type":"DRUG","name":"cyclophosphamide","otherNames":[]},{"type":"DRUG","name":"doxorubicin hydrochloride","otherNames":[]},{"type":"DRUG","name":"epirubicin hydrochloride","otherNames":[]},{"type":"DRUG","name":"fluorouracil","otherNames":[]},{"type":"DRUG","name":"paclitaxel","otherNames":[]}],"arms":[{"label":"Arm 1: CEF","type":"ACTIVE_COMPARATOR"},{"label":"Arm 2: EC/T","type":"ACTIVE_COMPARATOR"},{"label":"Arm 3: AC/T","type":"ACTIVE_COMPARATOR"}],"summary":"RATIONALE:\n\n1. . To compare the effects on breast cancer of three different combinations of drugs which are commonly used to treat this disease.\n2. . It is not yet known which treatment regimen is most effective for breast cancer.\n\nPURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy given with or without epoetin alfa in treating women who have undergone surgery for stage I, stage II, or stage III breast cancer.","primaryOutcome":{"measure":"Disease Free Survival","timeFrame":"13 years","effectByArm":[{"arm":"Arm 1: CEF","deltaMin":141,"sd":null},{"arm":"Arm 2: EC/T","deltaMin":135,"sd":null},{"arm":"Arm 3: AC/T","deltaMin":191,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"0.0007"}]},"eligibility":{"minAge":null,"sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":78,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":83,"n":680},"commonTop":["Fatigue","Alopecia","Nausea","Stomatitis","Hot flashes/ flushes"]}}